53, 9991012.10.1111/j.1365-313X.2007.03389.x 52 PolekhinaG.BoardP
Vyvanse : Vyvanse also contains dextroamphetamine and is FDA-approved to treat ADHD.[3] This prescription stimulant is also a central nervous system stimulant that increases neurotransmitters in the brain to accelerate functioning
Recent in vivo studies found a decrease of GSH in several areas of the brain from control, mild cognitive impairment, and AD subjects, which are correlated with cognitive decline
Q2: Is GHK-Cu FDA-approved
In an era of shrinking resources and bundling of dialysis services, the use of LC in dialysis patients will, appropriately, diminish. The authors concede that L-carnitine addresses problems in these patients but somehow concludes that it is appropriate for its use to diminish
Yet these therapies should be viewed as adjuncts, not replacements for established treatments